Review




Structured Review

Takeda myd88 mutation
Myd88 Mutation, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/myd88+protein/pm39218689-92-22-14
Average 90 stars, based on 1 article reviews
myd88 mutation - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

Mutagenesis:

Article Title: MYD88 mutation-positive indolent B-cell lymphoma with CNS involvement: Bing-Neel syndrome mimickers.
Article Snippet: .. Therefore, both types of lymphoma cells were suspected to be positive for the MYD88 Takeda K, et al. 3 BNS Mimickers with MYD88 Mutation mutation. ..



Similar Products

86
Abbott Laboratories myd88 l265p mutation pcr diagnostic test
Myd88 L265p Mutation Pcr Diagnostic Test, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/diagnostic+l265p+mutation+myd88+pcr+test/sec_filing____861838_slash_000119312514305621_slash_d749495dex103-9-7-4
Average 86 stars, based on 1 article reviews
myd88 l265p mutation pcr diagnostic test - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
Takeda myd88 mutation
Myd88 Mutation, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/myd88+protein/pm39218689-92-22-14
Average 90 stars, based on 1 article reviews
myd88 mutation - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Bio-Rad ddpcr assays myd88 l265p cxcr4 mutations
<t>CXCR4</t> mutations burden (%) distribution in MYD88 L265P‐positive bone marrow samples. (A) CXCR4 S338* C1013G and C1013A in IgM MGUS. (B) CXCR4 S338* C1013G and C1013A in smouldering Waldenström macroglobulinaemia (SWM).
Ddpcr Assays Myd88 L265p Cxcr4 Mutations, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/primepcr+preamp+sybr+green+assay++myd88++mouse/pmc10092069-52-6-11
Average 90 stars, based on 1 article reviews
ddpcr assays myd88 l265p cxcr4 mutations - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Kohlhammer GmbH oncogenically active myd88 mutations in human lymphoma
<t>CXCR4</t> mutations burden (%) distribution in MYD88 L265P‐positive bone marrow samples. (A) CXCR4 S338* C1013G and C1013A in IgM MGUS. (B) CXCR4 S338* C1013G and C1013A in smouldering Waldenström macroglobulinaemia (SWM).
Oncogenically Active Myd88 Mutations In Human Lymphoma, supplied by Kohlhammer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/myd88+mutations/pm35885931-481-16-1
Average 90 stars, based on 1 article reviews
oncogenically active myd88 mutations in human lymphoma - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Thermo Fisher myd88-mutated type (myd88-mut) report vector
<t>CXCR4</t> mutations burden (%) distribution in MYD88 L265P‐positive bone marrow samples. (A) CXCR4 S338* C1013G and C1013A in IgM MGUS. (B) CXCR4 S338* C1013G and C1013A in smouldering Waldenström macroglobulinaemia (SWM).
Myd88 Mutated Type (Myd88 Mut) Report Vector, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/pm34731782-62-10-42
Average 90 stars, based on 1 article reviews
myd88-mutated type (myd88-mut) report vector - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Thermo Fisher fam-labeled probe for the myd88 l265p mutation
<t>CXCR4</t> mutations burden (%) distribution in MYD88 L265P‐positive bone marrow samples. (A) CXCR4 S338* C1013G and C1013A in IgM MGUS. (B) CXCR4 S338* C1013G and C1013A in smouldering Waldenström macroglobulinaemia (SWM).
Fam Labeled Probe For The Myd88 L265p Mutation, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/myd88+sirna/pmc07339516-197-14-8
Average 90 stars, based on 1 article reviews
fam-labeled probe for the myd88 l265p mutation - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Qiagen primers specific for myd88 l265p mutation
<t>CXCR4</t> mutations burden (%) distribution in MYD88 L265P‐positive bone marrow samples. (A) CXCR4 S338* C1013G and C1013A in IgM MGUS. (B) CXCR4 S338* C1013G and C1013A in smouldering Waldenström macroglobulinaemia (SWM).
Primers Specific For Myd88 L265p Mutation, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/myd88+sirna/pm31953940-55-10-16
Average 90 stars, based on 1 article reviews
primers specific for myd88 l265p mutation - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Kohlhammer GmbH myd88 mutations
<t>CXCR4</t> mutations burden (%) distribution in MYD88 L265P‐positive bone marrow samples. (A) CXCR4 S338* C1013G and C1013A in IgM MGUS. (B) CXCR4 S338* C1013G and C1013A in smouldering Waldenström macroglobulinaemia (SWM).
Myd88 Mutations, supplied by Kohlhammer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/myd88+mutations/pm29482770-60-63-12
Average 90 stars, based on 1 article reviews
myd88 mutations - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Qiagen qbiomarker myd88 l265p somatic mutation assay
<t>CXCR4</t> mutations burden (%) distribution in MYD88 L265P‐positive bone marrow samples. (A) CXCR4 S338* C1013G and C1013A in IgM MGUS. (B) CXCR4 S338* C1013G and C1013A in smouldering Waldenström macroglobulinaemia (SWM).
Qbiomarker Myd88 L265p Somatic Mutation Assay, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myd88+mutation/myd88+sirna/10__1097_slash_01__hs9__0000566724__57428__ec-69-6-12
Average 90 stars, based on 1 article reviews
qbiomarker myd88 l265p somatic mutation assay - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


CXCR4 mutations burden (%) distribution in MYD88 L265P‐positive bone marrow samples. (A) CXCR4 S338* C1013G and C1013A in IgM MGUS. (B) CXCR4 S338* C1013G and C1013A in smouldering Waldenström macroglobulinaemia (SWM).

Journal: British Journal of Haematology

Article Title: Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia

doi: 10.1111/bjh.18502

Figure Lengend Snippet: CXCR4 mutations burden (%) distribution in MYD88 L265P‐positive bone marrow samples. (A) CXCR4 S338* C1013G and C1013A in IgM MGUS. (B) CXCR4 S338* C1013G and C1013A in smouldering Waldenström macroglobulinaemia (SWM).

Article Snippet: ddPCR assays for MYD88 L265P and CXCR4 mutations were commercially available (Bio‐Rad, Hercules, CA, USA).

Techniques:

Risk of progression to symptomatic Waldenström macroglobulinaemia. Cut‐off points were calculated using an X‐tile approach. Shown is the cumulative incidence of progression for both IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia considering MYD88 L265P and CXCR4 S338* C1013G tumour burden when assessed by droplet digital polymerase chain reaction in the bone marrow.

Journal: British Journal of Haematology

Article Title: Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia

doi: 10.1111/bjh.18502

Figure Lengend Snippet: Risk of progression to symptomatic Waldenström macroglobulinaemia. Cut‐off points were calculated using an X‐tile approach. Shown is the cumulative incidence of progression for both IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia considering MYD88 L265P and CXCR4 S338* C1013G tumour burden when assessed by droplet digital polymerase chain reaction in the bone marrow.

Article Snippet: ddPCR assays for MYD88 L265P and CXCR4 mutations were commercially available (Bio‐Rad, Hercules, CA, USA).

Techniques: Digital PCR